Does FLT3 Mutation Impact Survival after Hematopoietic Cell Transplant for AML? A CIBMTR Analysis

1. FLT3 mutation status does not impact overall survival after allogeneic hematopoietic stem cell transplant. 2. Pre-emptive strategies to reduce relapse need to be investigated in FLT3 mutated patients to further improve post HCT outcomes. BACKGROUND: Patients (pts) with FMS like tyrosine kinase 3...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer
Egile Nagusiak: Deol, Abhinav, Sengsayadeth, Salyka, Ahn, Kwang Woo, Wang, Hai-Lin, Aljurf, Mahmoud, Antin, Joseph Harry, Battiwalla, Minoo, Bornhauser, Martin, Cahn, Jean-Yves, Camitta, Bruce, Chen, Yi-Bin, Cutler, Corey S., Gale, Robert Peter, Ganguly, Siddhartha, Hamadani, Mehdi, Inamoto, Yoshihiro, Jagasia, Madan, Kamble, Rammurti, Koreth, John, Lazarus, Hillard M., Liesveld, Jane, Litzow, Mark R., Marks, David I., Nishihori, Taiga, Olsson, Richard F., Reshef, Ran, Rowe, Jacob M., Saad, Ayman A., Sabloff, Mitchell, Schouten, Harry C., Shea, Thomas C., Soiffer, Robert J., Uy, Geoffrey L., Waller, Edmond K., Wiernik, Peter H., Wirk, Baldeep, Woolfrey, Ann E., Bunjes, Donald, Devine, Steven, de Lima, Marcos, Sandmaier, Brenda M., Weisdorf, Dan, Khoury, Hanna Jean, Saber, Wael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5030151/
https://ncbi.nlm.nih.gov/pubmed/27315441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30140
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak